New drugs: ramelteon, tipranavir, nepafenac, and deferasirox.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences, PA, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D044482:Benzeneacetamides / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077588:Deferasirox; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007192:Indenes / Q000627:therapeutic use*; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D010648:Phenylacetates / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D013449:Sulfonamides; D014230:Triazoles / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D044482:Benzeneacetamides; D001565:Benzoates; D017320:HIV Protease Inhibitors; D006993:Hypnotics and Sedatives; D007192:Indenes; D007502:Iron Chelating Agents; D009883:Ophthalmic Solutions; D010648:Phenylacetates; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D014230:Triazoles; C414203:nepafenac; C495910:ramelteon; D000077588:Deferasirox; C107201:tipranavir